Ep 122 [10 January 2024]: Conversation with MaryAnne Rizk PhD (“Mar”), from Rizk Management Advisors, for a special “Live from JPM” episode. Building on Mar’s vast industry experience, she currently advises clients on the creation of strategic partnerships across the life science ecosystem. Mar will discuss the profound impact of RWD and the surge in Digital Health Technology adoptions. In this episode, we’ll unpack the significance of RWD within these clinical trials, exploring RWD’s pivotal role amidst the rise of digital health solutions. Additionally, we will unravel some of the latest insights from the FDA’s groundbreaking guidance on Digital Health Technology (December 2023), specifically its implications for remote care and impact on clinical investigation.